Sales Ended

Conference on Cell & Gene Therapy for HIV Cure 2017

Event Information

Share this event

Date and Time

Location

Location

Fred Hutchinson Cancer Research Center

1100 Fairview Avenue North

Seattle, WA 98109

View Map

Event description

Description

Keynote Speaker:

We are honored to announce Carl H. June, MD, as Keynote Speaker.

Dr. Carl June is currently Director of the Center for Cellular Immunotherapies and Director of Translational Research in the Abramson Cancer Center of the University of Pennsylvania, and is an Investigator of the Abramson Family Cancer Research Institute. Dr. June is the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania Perelman School Of Medicine.

In 2011, Dr. June’s research team published findings which represented the first successful and sustained demonstration of the use of gene transfer therapy to treat cancer. Clinical trials utilizing this approach, in which patients are treated with genetically engineered versions of their own T cells, are now underway for adults with chronic lymphocytic leukemia and adults and children with acute lymphoblastic leukemia. Early results in that group show that 90 percent of patients respond to the therapy, and more recently, trials of this approach have begun for patients with other blood cancers and solid tumors including pancreatic cancer, mesothelioma, and the brain cancer glioblastoma. In 2014, it became the first personalized cellular therapy for the treatment of cancer therapy to receive the U.S. Food and Drug Administration’s prestigi ous Breakthrough Therapy designation.

Dr. June's Keynote will address advancements in T cell therapies for HIV cure efforts, and the emerging intersection between curative treatments for cancer and HIV.

For conference updates: http://cgt4hivcure2017.org

Date and Time

Location

Fred Hutchinson Cancer Research Center

1100 Fairview Avenue North

Seattle, WA 98109

View Map

Save This Event

Event Saved